Literature DB >> 8471683

Spectral and topographic analysis of EEG in schizophrenic patients.

E M Kahn1, R D Weiner, R Coppola, H S Kudler, K Schultz.   

Abstract

The authors performed spectral analysis of electroencephalograms (EEG), recorded awake, with eyes closed, in 13 patients with schizophrenia and 9 age-matched individuals without psychiatric diagnosis. We tested several possible parameterizations of the data, and two data-reduction strategies; these yielded similar results. Comparison of the two groups revealed a relative increase in alpha frequency activity in the frontal regions in the patient group. The authors believe that this finding is consistent with data from neuropsychologic tests, metabolic imaging studies, and evoked potential studies that suggest impaired activation of frontal brain areas in patients with schizophrenia.

Entities:  

Mesh:

Year:  1993        PMID: 8471683     DOI: 10.1016/0006-3223(93)90296-p

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

Review 1.  The status of spectral EEG abnormality as a diagnostic test for schizophrenia.

Authors:  Nash N Boutros; Cynthia Arfken; Silvana Galderisi; Joshua Warrick; Garrett Pratt; William Iacono
Journal:  Schizophr Res       Date:  2007-12-21       Impact factor: 4.939

2.  Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia.

Authors:  Noah C Venables; Edward M Bernat; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2008-04-01       Impact factor: 9.306

3.  Quantitative electroencephalogram (QEEG) Spectrum Analysis of Patients with Schizoaffective Disorder Compared to Normal Subjects.

Authors:  Mahdi Moeini; Ali Khaleghi; Nasrin Amiri; Zahra Niknam
Journal:  Iran J Psychiatry       Date:  2014-10

4.  Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study.

Authors:  Pauline Soh; Balaji Narayanan; Sabin Khadka; Vince D Calhoun; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz; Godfrey D Pearlson
Journal:  Front Psychiatry       Date:  2015-11-09       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.